If you’ve ever been prescribed tramadol for chronic pain, new research may have you rethinking its benefits. A sweeping scientific review has revealed that this commonly used opioid provides only minimal relief for chronic pain, while simultaneously doubling the risk of serious side effects—particularly those affecting your heart.
Key Takeaways
- Tramadol only slightly reduces chronic pain—below levels deemed clinically important.
- The risk of serious side effects, especially heart issues, is significantly higher with tramadol.
- Researchers suggest minimizing use of tramadol and other opioids where possible.
Why Is Tramadol So Popular?
Tramadol is often trusted by doctors for treating moderate to severe pain, thanks to its dual-action as an opioid and because it’s considered “safer” and less addictive than other options. As a result, tramadol prescriptions have surged in recent years, especially in the United States. But this reputation for safety might be misleading.
What Did the Studies Actually Find?
To get a clear picture of tramadol’s real-world effects, scientists analyzed 19 clinical trials involving over 6,500 people experiencing various forms of chronic pain—including neuropathic pain, osteoarthritis, fibromyalgia, and chronic low back pain. Most participants took tramadol in tablet form, with treatment periods ranging from 2 to 16 weeks.
Minimal Pain Relief Doesn’t Add Up
So, did tramadol users feel better? Not enough. The combined results showed a slight reduction in pain, but the change wasn’t big enough to make a real difference in daily life. In other words, most patients might not notice enough improvement to justify staying on the medication.
Serious and Mild Side Effects Are a Real Concern
What did stand out was the risk. Eight trials that monitored side effects found tramadol roughly doubled the risk of serious health issues compared to a placebo, predominantly heart-related episodes like chest pain and heart failure. Milder problems—including nausea, dizziness, constipation, and sleepiness—were also more common in tramadol users.
Opioid Dangers Go Beyond Just Tramadol
The review puts tramadol’s risks into the wider context of the global opioid crisis. With millions worldwide struggling with opioid addiction and opioid-related deaths on the rise—rising from nearly 50,000 deaths in the U.S. in 2019 to over 81,000 in 2022—the call to limit opioid use, including tramadol, has never been louder.
Study Limitations and What You Should Know
Researchers admit that many of the trials they reviewed had potential bias, likely exaggerating tramadol’s benefits and underplaying its risks. All things considered, they advise that tramadol’s slight pain relief doesn’t outweigh its potential harms.
Bottom Line
If you are managing chronic pain, talk to your healthcare provider about alternative treatments. This new review suggests that, for most people, tramadol’s modest benefits aren’t worth the serious health risks.
Scientific References
- Tramadol and the risk of heart events: BMJ Evidence-Based Medicine, 2024
- Centers for Disease Control Opioid Data
- World Health Organization: Opioid Crisis Overview